Zealand Pharma A/S
ZLDPF
$64.38
$1.131.78%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -170.39M | -156.38M | -153.01M | -102.93M | -107.37M |
| Total Depreciation and Amortization | 3.24M | 3.36M | 3.36M | 3.06M | 3.95M |
| Total Amortization of Deferred Charges | 2.36M | 2.36M | 172.70K | 172.70K | 172.70K |
| Total Other Non-Cash Items | -1.32M | -2.01M | 12.32M | 12.95M | 24.79M |
| Change in Net Operating Assets | -7.21M | 17.42M | 36.28M | 12.92M | 12.33M |
| Cash from Operations | -173.33M | -135.26M | -100.87M | -73.81M | -66.12M |
| Capital Expenditure | -1.85M | -1.45M | -2.26M | -2.34M | -1.98M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 3.33M | -- | -- | -- | -- |
| Other Investing Activities | -801.26M | -1.08B | -1.10B | -178.40M | -349.13M |
| Cash from Investing | -799.77M | -1.08B | -1.10B | -180.75M | -351.11M |
| Total Debt Issued | 0.00 | 369.87M | 369.87M | 369.87M | 369.87M |
| Total Debt Repaid | -16.92M | -16.44M | -20.49M | -18.99M | -544.28M |
| Issuance of Common Stock | 7.05B | 8.52B | 8.54B | 8.54B | 3.01B |
| Repurchase of Common Stock | -351.83M | -351.83M | -351.83M | -81.03M | -41.60M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -213.63M | -236.58M | -237.06M | -234.71M | -94.86M |
| Cash from Financing | 932.17M | 1.20B | 1.20B | 1.24B | 393.34M |
| Foreign Exchange rate Adjustments | -45.90K | 893.10K | -626.40K | 430.60K | 474.20K |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | 100.00 | -- |
| Net Change in Cash | -40.99M | -15.57M | -1.82M | 985.56M | -23.42M |